Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | $12.0K | $86.0K |
| Revenue growth | — | — | 616.7% |
| Operating income | -$49.7M | -$30.0M | -$23.8M |
| Operating margin | — | -250341.7% | -27661.6% |
| Net income | -$48.8M | -$18.5M | -$46.9M |
| Net margin | — | -153825.0% | -54517.4% |
| EPS (diluted) | -$3.32 | -$1.15 | -$1.35 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$10.7M | -$15.8M | -$12.5M |
| Capital expenditures | $316K | $277K | $8.00K |
| Free cash flow | -$11.1M | -$16.1M | -$12.5M |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $22.1M | $5.86M | $15.0M |
| Total assets | $23.8M | $17.0M | $20.4M |
| Total liabilities | $2.96M | $5.83M | $7.06M |
| Shareholders' equity | $20.8M | $11.2M | $13.4M |
| Retained earnings | -$92.2M | -$111M | -$158M |
| Shares (wtd avg diluted) | 15.4M | 16.2M | 34.5M |
Every figure is extracted from Incannex Healthcare Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.